Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

293 (8%)

Anticipated shortage:

6 (0%)

Avoided shortage:

11 (0%)

Resolved:

3320 (91%)

3630

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

30 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TRI-CIRA LO 21 0.18MG 0.025MG 0.025MG 0.25MG 0.025MG 0.215MG TABLET Resolved 2025-07-31 2025-08-15 263987
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-02-22 2022-03-07 155371
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-11-13 2019-11-18 98575
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-01-18 2018-02-23 36429
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-12-27 2019-01-23 70526
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-05 2019-05-21 77902
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-13 2019-05-21 78558
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-04-10 2019-08-26 80931
TRICIRA LO 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-08-07 2019-08-26 91109
TRIMEBUTINE 100MG TABLET Resolved 2023-02-03 2023-04-17 183589
TRIMEBUTINE 100MG TABLET Resolved 2021-11-24 2021-12-24 149793
TRIMEBUTINE 100MG TABLET Resolved 2023-07-14 2023-08-14 198716
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-11-17 2023-12-22 210668
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-06-16 2023-07-27 195081
ZAMINE 21 0.03MG 3MG TABLET Resolved 2024-02-02 2024-03-29 218391
ZAMINE 21 3.0MG 0.030MG TABLET Resolved 2017-03-11 2020-09-04 558
ZAMINE 28 3MG 0.03MG TABLET Resolved 2021-02-12 2021-03-10 133984
ZAMINE 28 0.03MG 3MG TABLET Resolved 2023-11-24 2023-12-22 211487
ZAMINE 28 0.03MG 3MG TABLET Resolved 2025-10-30 2025-12-05 270732
ZAMINE 28 0.03MG 3MG TABLET Resolved 2026-01-15 2026-01-23 276169

Showing 3601 to 3620 of 3630

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60288
APO-BOSENTAN 125.0MG TABLET Discontinued 2019-01-04 2019-01-04 71342
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BOSENTAN 125.0MG TABLET Discontinued 2018-09-07 2018-10-31 60291
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BROMAZEPAM - TAB 1.5MG 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-BROMAZEPAM - TAB 3MG 3MG TABLET Discontinued 2018-09-07 2019-06-12 60307
APO-BROMAZEPAM - TAB 6MG 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-CANDESARTAN 32MG TABLET Discontinued 2018-09-07 2018-09-15 60328
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 4MG TABLET Discontinued 2018-09-07 2018-09-15 60319
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047

Showing 81 to 100 of 366